$5.50
-0.34-5.82%
Last update: Nov 5, 7:25 PM
Eikon Therapeutics Inc
EIKNNASDAQ
The average analyst price target for Eikon Therapeutics is $24.67, 348.5% above the current price. Of 7 analysts, 6 rate it Buy and 1 Sell. Targets range from $4 to $34. The latest change came on Oct 16, 2026, when HC Wainwright & Co. initiated coverage of Eikon Therapeutics with a Buy rating and a $23 price target.
Price Target Range — 4 Quarters
Analyst Consensus — 7 Analysts
Rating Trend — Last 9 Months
